Interleukin Genetics Files Form 15
14 août 2017 10h20 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced it has filed a Form 15 with the Securities and Exchange Commission completing the process of...
Interleukin Genetics Files Form 25
04 août 2017 08h00 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Aug. 04, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced it has filed a Form 25 with the Securities and Exchange Commission in furtherance of its...
Interleukin Genetics to Wind-Up and Pursue a Plan of Liquidation
24 juil. 2017 16h29 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced the adoption of a plan to wind-up and liquidate the Company subject to shareholder approval...
Interleukin Genetics To Explore Strategic Alternatives, Reduce Workforce
03 juil. 2017 08h00 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., July 03, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced that it will pursue strategic alternatives for the Company and will reduce the Company’s...
Interleukin Genetics Reports First Quarter 2017 Financial Results
12 mai 2017 08h00 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., May 12, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced financial results for its first quarter of 2017, ended March 31, 2017, and provided a...
Interleukin Genetics Reports Fourth Quarter and Year-End 2016 Financial Results
18 avr. 2017 08h00 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., April 18, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, today announced financial and...
Interleukin-1 Genotypes Are Predictive of Cardiovascular Events in Patients With Elevated Lipoprotein (a)
20 mars 2017 08h00 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., March 20, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today the presentation...
Interleukin Genetics Signs Second Employer Agreement in Pittsburgh Region
13 mars 2017 08h00 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., March 13, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has...
Interleukin Genetics Establishes Partnership with Greater Philadelphia Business Coalition on Health
02 mars 2017 08h00 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., March 02, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has...
Interleukin Genetics Deploys ILUSTRA™ Inflammation Management Program with mPulse Mobile Employees
23 févr. 2017 08h00 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has...